Familial Hypercholesterolemia in the Danish General Population: Prevalence, Coronary Artery Disease, and Cholesterol-Lowering Medication
The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Abstract
Context: The diagnosis of familial hypercholesterolemia (FH) can be made using the Dutch Lipid Clinic Network criteria. This employs the personal and family history of premature coronary artery disease and hypercholesterolemia and the presence of a pathogenic mutation in the low-density lipoprotein receptor (LDLR) and apolipoprotein B (APOB) genes. Objective: We employed this tool to investigate the prevalence of FH and the associations between FH and coronary artery disease and cholesterol-lowering medication in the Copenhagen General Population Study. Setting: The study was of an unselected, community-based population comprising 69,016 participants. Main Outcome Measures: FH (definite/probable) was defined as a Dutch Lipid Clinic Network score higher than 5. Coronary artery disease was myocardial infarction or angina pectoris. Results: The prevalence of FH was 0.73% (one in 137). Of participants with FH, 20% had an LDLR or APOB mutation. The prevalence of coronary artery disease among FH participants was 33%. Only 48% of subjects with FH admitted to taking cholesterol-lowering medication. The odds ratio for coronary artery disease off cholesterol-lowering medication was 13.2 (10.0–17.4) in definite/probable FH compared with non-FH subjects, after adjusting for age, gender, body mass index, hypertension, metabolic syndrome and diabetes, and smoking. The corresponding adjusted odds ratio for coronary artery disease in FH subjects on cholesterol-lowering medication was 10.3 (7.8–13.8). Conclusion: The prevalence of FH appears to be higher than commonly perceived in a general population of white Danish individuals, with at least half of affected subjects not receiving cholesterol-lowering medication. The very high risk of coronary artery disease irrespective of use of medication reflects the extent of underdiagnosis and undertreatment of FH in the community and primary care.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The frequency of HeFH in the population has earlier been estimated at 1/500; however, recent studies from whole populations suggest that the frequency is higher, in some populations as high as 1/137. 297”
From 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias (2016) · cites this paper as [297]
Citations
Cites
Alberti, K. G. M. M., Eckel, R. H., Grundy, S. M., Zimmet, P. Z., Cleeman, J. I., Donato, K. A., Fruchart, J.-C., James, W. P. T., Loria, C. M., & Smith, S. C. (2009) · Circulation · doi:10.1161/circulationaha.109.192644 · Cited by 14,860
ESC/EAS Guidelines for the management of dyslipidaemias
Reiner, Ž., Catapano, A. L., De Backer, G., Graham, I., Taskinen, M.-R., Wiklund, O., Agewall, S., Alegria, E., Chapman, M. J., Durrington, P., et al. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehr158 · Cited by 3,549
(2003) · Journal of Hypertension · doi:10.1097/00004872-200311000-00002 · Cited by 2,672
Nordestgaard, B. G., Benn, M., Schnohr, P., & Tybjærg-Hansen, A. (2007) · JAMA · doi:10.1001/jama.298.3.299 · Cited by 2,058
Self-citationJones, P. H., Davidson, M. H., Stein, E. A., Bays, H. E., McKenney, J. M., Miller, E., Cain, V. A., & Blasetto, J. W. (2003) · The American Journal of Cardiology · doi:10.1016/s0002-9149(03)00530-7 · Cited by 1,398
Genetically elevated C-reactive protein and ischemic vascular disease
Zacho, J., Tybjærg-Hansen, A., Jensen, J. S., Grande, P., Sillesen, H., & Nordestgaard, B. G. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0707402 · Cited by 839
Self-citationKotseva, K., Wood, D., Backer, G. D., Bacquer, D. D., Pyörälä, K., Keil, U., & EUROASPIRE Study Group (2009) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1097/hjr.0b013e3283294b1d · Cited by 812
Efficacy of statins in familial hypercholesterolaemia: a long term cohort study
Versmissen, J., Oosterveer, D. M., Yazdanpanah, M., Defesche, J. C., Basart, D. C. G., Liem, A. H., Heeringa, J., Witteman, J. C., Lansberg, P. J., Kastelein, J. J. P., et al. (2008) · BMJ · doi:10.1136/bmj.a2423 · Cited by 721
ESC/EAS Guidelines for the management of dyslipidaemias
Catapano, A. L., Reiner, Ž., De Backer, G., Graham, I., Taskinen, M.-R., Wiklund, O., Agewall, S., Alegria, E., Chapman, M. J., Durrington, P., et al. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.06.028 · Cited by 706
Research works printed but not linked: 1
- World Health Organization, 1999, Familial hypercholesterolaemia (FH)
Cited by
Items 301–400 of 632
Wang, H., Yang, H., Liu, Z., Cui, K., Zhang, Y., Zhang, Y., Zhao, K., Yin, K., Li, W., & Zhou, Z. (2020) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.54593 · Cited by 16
Latvian registry of familial hypercholesterolemia: The first report of three-year results
Latkovskis, G., Saripo, V., Gilis, D., Nesterovics, G., Upena-Roze, A., & Ērglis, A. (2018) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2018.06.011 · Cited by 18
Scicali, R., Pino, A. D., Urbano, F., Ferrara, V., Marchisello, S., Mauro, S. D., Scamporrino, A., Filippello, A., Piro, S., Rabuazzo, A. M., et al. (2019) · Acta Diabetologica · doi:10.1007/s00592-019-01338-1 · Cited by 16
Jones, L. K., Gidding, S. S., Seaton, T., Goldberg, A. C., Gregor, C. M., Sturm, A. C., Brownson, R. C., Rahm, A. K., & Williams, M. S. (2019) · Research in Social and Administrative Pharmacy · doi:10.1016/j.sapharm.2019.06.006 · Cited by 16
Elis, A., Leventer‐Roberts, M., Bachrach, A., Lieberman, N., Durst, R. Y., Knobler, H., & Balicer, R. D. (2019) · QJM · doi:10.1093/qjmed/hcz327 · Cited by 20
Zafrir, B., Jubran, A., Lavie, G., Halon, D. A., Flugelman, M. Y., & Shapira, C. (2017) · Circulation Journal · doi:10.1253/circj.cj-17-0392 · Cited by 16
Nor, N. S. M., Al-Khateeb, A. M., Chua, Y.-A., Kasim, N. A. M., & Nawawi, H. M. (2019) · BMC Pediatrics · doi:10.1186/s12887-019-1474-y · Cited by 24
Familial Hypercholesterolemia (FH) Registry Worldwide: A Systematic Review
Amerizadeh, A., Javanmard, S. H., Sarrafzadegan, N., & Vaseghi, G. (2021) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2021.100999 · Cited by 18
Clinical utility gene card for: Hyperlipoproteinemia, TYPE II
Kassner, U., Wühle-Demuth, M., Missala, I., Humphries, S. E., Steinhagen‐Thiessen, E., & Demuth, I. (2013) · European Journal of Human Genetics · doi:10.1038/ejhg.2013.271 · Cited by 15
Factors Affecting Pediatric Dyslipidemia Screening and Treatment
Herrington, L., Susi, A., Gorman, G. H., Nylund, C. M., & Hisle-Gorman, E. J. (2019) · Clinical Pediatrics · doi:10.1177/0009922819832068 · Cited by 15
Does the LDL Receptor Play a Role in the Risk of Developing Type 2 Diabetes?
Preiss, D., & Sattar, N. A. (2015) · JAMA · doi:10.1001/jama.2015.1275 · Cited by 18
Teng, H., Gao, Y., Wu, C., Zhang, H., Zheng, X., Lu, J., Li, Y., Wang, Y., Gao, Y., Yang, Y., et al. (2022) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2022.03.027 · Cited by 14
A comparison of European and US guidelines for familial hypercholesterolaemia
Reiner, Ž. (2015) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000178 · Cited by 16
Casula, M., Scotti, L., Tragni, E., Merlino, L. G., Corrao, G., & Catapano, A. L. (2016) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2016.10.020 · Cited by 18
Bjelakovic, B. B., Stefanutti, C., Reiner, Ž., Watts, G. F., Moriarty, P. M., MARAIS, D. P., Widhalm, K., Cohen, H., Harada‐Shiba, M., & Banach, M. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10214930 · Cited by 15
Self-citationHovingh, G. K., Goldberg, A. C., & Moriarty, P. M. (2017) · Journal of clinical lipidology · doi:10.1016/j.jacl.2017.03.008 · Cited by 15
Petrov, I. S., Dumitrescu, A., Šnejdrlová, M., Zafrir, B., Wożakowska−Kapłon, B., Fábryová, Ľ., Pintarić, H., Bridges, I. M., & Petkova, R. T. (2019) · Advances in Therapy · doi:10.1007/s12325-019-0879-1 · Cited by 19
Benekos, T., Kosmeri, C., Vlahos, A. P., & Milionis, H. J. (2020) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2019-0250 · Cited by 14
Futema, M., Kumari, M., Boustred, C., Kivimäki, M., & Humphries, S. E. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.01.028 · Cited by 17
Liu, H., Zhang, Y., Zhao, Y., Li, Y., Zhang, X., Bao, L., Yan, R., Yang, Y., Zhou, H., Zhang, J., et al. (2025) · Genes · doi:10.3390/genes16010098 · Cited by 15
Novel genes in LDL metabolism – a comprehensive overview
Christoffersen, M., & Tybjærg‐Hansen, A. (2015) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000175 · Cited by 18
Cao, Y., Liu, H., Jin, J., Sun, D., Guo, Y., Wu, N., Zhu, C., Xu, R., Sun, J., Santos, R. D., et al. (2019) · European Journal of Preventive Cardiology · doi:10.1177/2047487319880985 · Cited by 13
Patient Perspectives Regarding Genetic Testing for Familial Hypercholesterolemia
Marchand, M., Chen, V., Trinder, M., Cermakova, L., & Brunham, L. R. (2020) · CJC Open · doi:10.1016/j.cjco.2020.12.006 · Cited by 13
Qureshi, N., Silva, M. L. R. D., Abdul-Hamid, H., Weng, S. F., Kai, J., & Leonardi‐Bee, J. (2021) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012985.pub2 · Cited by 21
Cardiovascular Risk and Treatment Outcomes in Severe Hypercholesterolemia: A Nationwide Cohort Study
Lee, C. J., Park, S., Han, K., & Lee, S. (2022) · Journal of the American Heart Association · doi:10.1161/jaha.121.024379 · Cited by 13
McKay, A. J., Gunn, L. H., & Ray, K. K. (2022) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2022.07.011 · Cited by 13
Identification and Functional Analysis of APOB Variants in a Cohort of Hypercholesterolemic Patients
Rodríguez‐Jiménez, C., de la Peña, G., Sanguino, J., Poyatos-Peláez, S., Carazo, A., Martínez-Hernández, P. L., Arrieta, F., Mostaza, J. M., Gómez‐Coronado, D., & Rodríguez‐Nóvoa, S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24087635 · Cited by 13
Jarauta, E., Pérez-Ruiz, M. R., Pérez‐Calahorra, S., Mateo‐Gállego, R., Cenarro, A., Cofán, M., Ros, E., Civeira, F., & Tejedor, M. T. (2016) · Journal of clinical lipidology · doi:10.1016/j.jacl.2016.09.011 · Cited by 13
Bahia, L., Rosa, R. D. S., Santos, R. D., & Araújo, D. V. (2018) · Archives of Endocrinology and Metabolism · doi:10.20945/2359-3997000000030 · Cited by 14
Eid, W., Sapp, E. H., McCreless, T., Nolan, J. R., & Flerlage, E. (2020) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2020.07.008 · Cited by 16
Santos, R. D., Pereira, C., Cesena, F. Y., Laurinavicius, A. G., Tabone, V. A., & Bittencourt, M. S. (2021) · Arquivos Brasileiros de Cardiologia · doi:10.36660/abc.20190516 · Cited by 16
Soukup, J., Zierhut, H. A., & Ison, H. E. (2021) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2021.02.065 · Cited by 15
Bell, D. A., Edwards, G., Hooper, A. J., McMahon, J., BOCKXMEER, F. M. V., Watts, G. F., & Burnett, J. R. (2015) · Clinica Chimica Acta · doi:10.1016/j.cca.2015.06.004 · Cited by 13
Self-citationRay, K. K., Pillas, D., Hadjiphilippou, S., Khunti, K., Seshasai, S. R. K., Vallejo‐Vaz, A. J., Neasham, D., & Addison, J. (2023) · American Journal of Preventive Cardiology · doi:10.1016/j.ajpc.2023.100580 · Cited by 15
Shetty, N. S., Gaonkar, M. P., Patel, N., Knowles, J. W., Natarajan, P., Arora, G., & Arora, P. K. (2024) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2023.09.016 · Cited by 12
Rabacchi, C., Bigazzi, F., Puntoni, M., Sbrana, F., Sampietro, T., Tarugi, P., Bertolini, S., & Calandra, S. (2016) · Journal of clinical lipidology · doi:10.1016/j.jacl.2016.04.005 · Cited by 13
Averkova, A. O., Brazhnik, V. A., Сергеевна, К. О., Zubova, E., Hasanov, N., Chichkov, Y. M., Chichkova, M., Kozlova, O. G., Kovalenko, N., & Kosmacheva, E. D. (2017) · Medical news of the North Caucasus · doi:10.14300/mnnc.2017.12001 · Cited by 12
Jung, K. J., Koh, H., Choi, Y. J., Lee, S. J., Ji, E., & Jee, S. H. (2018) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2018.09.012 · Cited by 13
Electronic health records to facilitate continuous detection of familial hypercholesterolemia
Pepplinkhuizen, S., Ibrahim, S., Vink, R., de Groot, B., Stroes, E. S. G., Bax, W. A., & Cornel, J. H. (2020) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2020.07.022 · Cited by 13
Novel therapies for familial hypercholesterolemia
Mohamed, F., Seedat, F., & Raal, F. J. (2020) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000590 · Cited by 16
Liu, C., Lai, P., Guo, J., Wang, Y., & Xian, X. (2021) · Medical Review · doi:10.1515/mr-2021-0004 · Cited by 16
New EAS Consensus Statement on FH: Improving the care of FH patients
Stock, J. K. (2013) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2013.08.035 · Cited by 14
Mangili, L. C., Mangili, O. C., Bittencourt, M. S., Miname, M. H., Harada, P. H. N., Lima, L. M., Rochitte, C. E., & Santos, R. D. (2016) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2016.09.010 · Cited by 14
Leng, Z., Li, R., Li, Y., Wang, L., Wang, Y.-L., & Yang, Y. (2017) · Echocardiography · doi:10.1111/echo.13442 · Cited by 12
Kaestner, T. L. D. L., Bento, V. F. R., Pazin, D. C., Baena, C. P., Olandoski, M., Abreu, G. D. A., Kuschnir, M. C. C., Bloch, K. V., & Faria‐Neto, J. R. (2017) · Journal of clinical lipidology · doi:10.1016/j.jacl.2017.12.009 · Cited by 12
A Novel Modified System of Simplified Chinese Criteria for Familial Hypercholesterolemia (SCCFH)
Cao, Y., Sun, D., Liu, H., Jin, J., Li, S., Guo, Y., Wu, N., Zhu, C., Gao, Y., Dong, Q., et al. (2019) · Molecular Diagnosis & Therapy · doi:10.1007/s40291-019-00405-1 · Cited by 13
Takasaki, A., Kurita, T., Masuda, J., Hoshino, K., Seko, T., Tanigawa, T., Kitamura, T., Ichikawa, T., Ito, M., & Dohi, K. (2020) · Circulation Journal · doi:10.1253/circj.cj-20-0112 · Cited by 12
Diagnóstico y tratamiento de la hipercolesterolemia familiar en España: documento de consenso
Mata, P., Rodrigo Alonso, K., Ruiz, A., González‐Juanatey, J. R., Badimón, L., Díaz-Díaz, J. L., Múñoz, M. T., Muñiz-Grijalvo, O., Galve, E., Irigoyen, L., et al. (2014) · Medicina de Familia SEMERGEN · doi:10.1016/j.semerg.2014.05.001 · Cited by 15
Genetic, hematological, and immunological disorders transmissible with liver transplantation
Tan, A., Florman, S. S., & Schiano, T. D. (2017) · Liver Transplantation · doi:10.1002/lt.24755 · Cited by 13
Matsumoto, I., Kurozumi, M., Namba, T., & Takagi, Y. (2022) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.63607 · Cited by 14
de Araújo, A. L. V., Santos, R. D., Bittencourt, M. S., Dantas, R. N., Oshiro, C. A., Nomura, C. H., Bor‐Seng‐Shu, E., Oliveira, M. D. L., Leite, C. D. C., Martin, M. D. G. M., et al. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2023.1082275 · Cited by 13
Genetic Testing for Familial Hypercholesterolemia in Clinical Practice
Tricou, E. P., Morgan, K., Betts, M. N., & Sturm, A. C. (2023) · Current Atherosclerosis Reports · doi:10.1007/s11883-023-01094-2 · Cited by 12
Hedegaard, B. S., Bork, C. S., Kanstrup, H., Thomsen, K. K., Heitmann, M., Bang, L. E., Henriksen, F. L., Andersen, L. J., Gohr, T., Mouridsen, M. R., et al. (2023) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2023.04.003 · Cited by 12
Self-citationHauguel‐Moreau, M., Aïdan, V., Hergault, H., Beauchet, A., Pépin, M., Prati, G., Pillière, R., Ouadahi, M., Josseran, L., Rodon, C., et al. (2022) · Archives of cardiovascular diseases · doi:10.1016/j.acvd.2021.11.005 · Cited by 15
Management of Familial Hypercholesterolemia in Hong Kong
Hu, M., Hooper, A. J., BOCKXMEER, F. M. V., Watts, G. F., Chan, J. C. N., & Tomlinson, B. (2016) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.34314 · Cited by 11
Self-citationPavloušková, J., Réblová, K., Tichý, L., Freiberger, T., & Fajkusová, L. (2016) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2016.04.022 · Cited by 11
Pang, J., Marais, A. D., Blom, D. J., Brice, B. C., Silva, P. R. D. S., Jannes, C. E., Pereira, A. C., Hooper, A. J., Ray, K. K., Santos, R. D., et al. (2018) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2018.06.822 · Cited by 11
Self-citationReclassifying Risk in Familial Hypercholesterolemia
Shapiro, M. D., & Blankstein, R. (2018) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2018.10.010 · Cited by 11
Diboun, I., Al-Sarraj, Y. A., Toor, S. M., Mohammed, S., Qureshi, N., Hail, M. S. H. A., Jayyousi, A., Suwaidi, J. M. S. A., & Albagha, O. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.927504 · Cited by 13
Zafrir, B., Shapira, C., Lavie, G., Halon, D. A., & Flugelman, M. Y. (2016) · Journal of clinical lipidology · doi:10.1016/j.jacl.2016.08.010 · Cited by 10
Retargeting the management of hypercholesterolemia – focus on evolocumab
Cicero, A. F. G., Colletti, A., & Derosa, G. (2016) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s116679 · Cited by 11
What characterizes event-free elderly FH patients? A comprehensive lipoprotein profiling
Melnes, T., Bogsrud, M. P., Thorsen, I., Fossum, J., Christensen, J. J., Narverud, I., Retterstøl, K., Ulven, S. M., & Holven, K. B. (2022) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2022.03.028 · Cited by 12
Genetic Testing for Familial Hypercholesterolemia in a Pediatric Group: A Romanian Showcase
Constantin, A. T., Streață, I., Covăcescu, M., Riza, A. L., Roșca, I., Delia, C., Tudor, L. M., Dorobantu, S., Dragos, A., Ristea, D., et al. (2023) · Diagnostics · doi:10.3390/diagnostics13121988 · Cited by 12
Kayıkçıoğlu, M., Başaran, Ö., Doğan, V., Mert, K. U., Mert, G. Ö., Özdemir, İ. H., Rencüzoğulları, İ., Karadeniz, F. Ö., Tekinalp, M., Aşkın, L., et al. (2023) · Journal of clinical lipidology · doi:10.1016/j.jacl.2023.09.013 · Cited by 11
Martin, R. J. L., Latten, M. J., Hart, P., Murray, H. A., Bailie, D. A., Crockard, M. A., Lamont, J. V., FitzGerald, P. S., & Graham, C. A. (2016) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2016.09.061 · Cited by 14
Češka, R., Freiberger, T., Susekov, A. V., Paragh, G., Reiner, Ž., Tokgözoğlu, L. S., Rašlová, K., Banach, M., Vohnout, B., Rynkiewicz, A., et al. (2017) · Vnitřní lékařství · doi:10.36290/vnl.2017.005 · Cited by 11
Improving Familial Hypercholesterolemia Diagnosis Using an EMR-based Hybrid Diagnostic Model
Eid, W., Sapp, E. H., Wendt, A., Lumpp, A., & Miller, C. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab873 · Cited by 12
Waluś‐Miarka, M., Czarnecka, D., Kloch‐Badełek, M., Wojciechowska, W., Kapusta, M., & Malecki, M. T. (2017) · International Journal of Cardiology · doi:10.1016/j.ijcard.2017.06.076 · Cited by 11
Borissov, B., Urbich, M., Georgieva, B., Tsenov, S., & Villa, G. (2017) · Journal of Market Access & Health Policy · doi:10.1080/20016689.2017.1412753 · Cited by 10
How well can familial hypercholesterolemia be identified in an electronic health record database?
Mues, K. E., Bogdanov, A., Monda, K. L., Yedigarova, L., Liede, A., & Kallenbach, L. (2018) · Clinical Epidemiology · doi:10.2147/clep.s176853 · Cited by 12
Maniya, M. T., Siddiqi, A. K., Shahzad, M., Ali, K. M., Chachar, M. A., Amin, S., Garcia, M. C., & Naeem, M. (2025) · Hellenic Journal of Cardiology · doi:10.1016/j.hjc.2025.06.001 · Cited by 10
Arca, M. (2016) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2016.09.001 · Cited by 12
Targeted exome sequencing in South Indian patients with Familial hypercholesterolemia
Pillai, K. K. B., Shah, S. A. V., Reddy, L. L., Ashavaid, T. F., & Viswanathan, S. K. (2022) · Clinica Chimica Acta · doi:10.1016/j.cca.2021.12.022 · Cited by 9
Vohnout, B., Fábryová, Ľ., Klabník, A., Kadurová, M., Bálinth, K., Kozárová, M., Bugáňová, I., Sirotiaková, J., & Rašlová, K. (2018) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2018.06.857 · Cited by 9
Monogenetic disorders of the cholesterol metabolism and premature cardiovascular disease
van Schie, M. C., Jainandunsing, S., & van Lennep, J. E. R. (2017) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2017.09.046 · Cited by 11
Lipid profile assessed in the family pediatrician’s office: the COLIBRI’- SIMPeF study
Giussani, M., Antolini, L., Angelis, M. D., Guardamagna, O., Dozzi, M., & Genovesi, S. (2020) · European Journal of Pediatrics · doi:10.1007/s00431-020-03726-0 · Cited by 10
Jarauta, E., Bea, A. M., Marco-Benedí, V., & Lamíquiz-Moneo, I. (2020) · Frontiers in Genetics · doi:10.3389/fgene.2020.554931 · Cited by 9
Yao, H., Farnier, M., Tribouillard, L., Chague, F., Brunel, P., Maza, M., Brunet, D., Rochette, L., Bichât, F., Cottin, Y., et al. (2021) · Lipids in Health and Disease · doi:10.1186/s12944-021-01467-z · Cited by 10
Kheiri, B., Simpson, T. F., Osman, M., Balla, S., Rahmouni, H. W., Mehta, A., Pokharel, Y., Nasir, K., Fazio, S., & Shapiro, M. D. (2021) · Journal of clinical lipidology · doi:10.1016/j.jacl.2021.04.005 · Cited by 9
Familial Hypercholesterolaemia ☆
Humphries, S. E. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-809633-8.06415-3 · Cited by 9
Masson, W. M., Corral, P., Barbagelata, L., Cobo, A. L., Nogueira, J. P., Siniawski, D. A., & Ray, K. K. (2022) · Journal of clinical lipidology · doi:10.1016/j.jacl.2022.07.004 · Cited by 9
Familial Hypercholesterolemia Among Young Adults With Acute Coronary Syndrome
Haskiah, F., Erez, D., & Khaskia, A. (2022) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2022.09.026 · Cited by 11
Sönmez, A., Demirci, İ., Haymana, C., Taşçı, İ., Ayvalı, M. O., Ata, N., Ezgü, F. S., Bayram, F., Barçın, C., Çağlayan, M., et al. (2023) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2023.04.011 · Cited by 13
Hipercolesterolemia familiar en la infancia y la adolescencia: una realidad oculta
Plana, N., Rodríguez-Borjabad, C., Ibarretxe, D., & Masana, L. (2017) · Clínica e Investigación en Arteriosclerosis · doi:10.1016/j.arteri.2016.11.002 · Cited by 11
Hypercholestérolémie familiale : un risque cardiovasculaire largement sous-estimé
Ferrières, J., Bruckert, É., Béliard, S., Rabès, J., Farnier, M., Krempf, M., Cariou, B., & Danchin, N. (2017) · Annales de Cardiologie et d Angéiologie · doi:10.1016/j.ancard.2017.04.015 · Cited by 10
Clinical Application of Genetic Testing in Heart Failure
Morales, A., & Hershberger, R. E. (2017) · Current Heart Failure Reports · doi:10.1007/s11897-017-0366-4 · Cited by 10
Peterlin, A., Petrovič, D., & Peterlin, B. (2018) · Current Vascular Pharmacology · doi:10.2174/1570161116666180206111725 · Cited by 9
Semenkovich, C. F., Goldberg, A. C., & Goldberg, I. J. (2016) · Elsevier eBooks · doi:10.1016/b978-0-323-29738-7.00037-x · Cited by 23
Genetics of Coronary Atherosclerosis
Aragam, K. G., & Kathiresan, S. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-42880-4.00003-0 · Cited by 9
Daniels, S. R. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.06.1340 · Cited by 9
Integrating New Technologies in Lipidology: A Comprehensive Review
Escobar, C., García, J. S., Torremocha, A., Lorenzo, C. C., Lara-García, A., Muñoz, L. C., González, R. M., García, J. V., & Banach, M. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14144984 · Cited by 11
Lorea, A. E., Ruiz, M. V., de Esteban, J. P. M., Torres, J. G., Artajo, J. D. C., & Anda, E. (2025) · Acta cardiologica. Supplementum · doi:10.1080/00015385.2025.2597126 · Cited by 8
Almigbal, T. H., Batais, M. A., Hasanato, R. M. W., Alharbi, F. K., Khan, I. A., & Alharbi, K. K. (2018) · Acta Biochimica Polonica · doi:10.18388/abp.2017_2344 · Cited by 8
Jones, L. K., Chen, N., Hassen, D. A., Betts, M. N., Klinger, T., Hartzel, D. N., Veenstra, D. L., Spencer, S., Snyder, S. R., Peterson, J. F., et al. (2022) · Circulation Genomic and Precision Medicine · doi:10.1161/circgen.121.003549 · Cited by 7
Familial hypercholesterolemia in pregnancy
Alnouri, F., & Raal, F. (2025) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000980 · Cited by 9
Emerging PCSK9 inhibitors for treating dyslipidaemia: buttressing the gaps in coronary prevention
Page, M. M., & Watts, G. F. (2015) · Expert Opinion on Emerging Drugs · doi:10.1517/14728214.2015.1035709 · Cited by 9
Self-citationMattina, A., Rosenbaum, D. H., Bittar, R., Bonnefont‐Rousselot, D., Noto, D., Averna, M. R., Bruckert, É., & Giral, P. (2018) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2018.01.012 · Cited by 10
Mülverstedt, S., Hildebrandt, P. R., Prescott, E., & Heitmann, M. (2020) · BJGP Open · doi:10.3399/bjgpopen20x101142 · Cited by 11
Familial Hypercholesterolemia (FH) in Iran: Findings from the Four-Year FH Registry
Vaseghi, G., Taheri, M., Heshmat‐Ghahdarijani, K., Rayati, M., Zarfeshani, S., Pourmoghaddas, A., Khosravi, A., Zarepour, E., Keshavarzrad, P., Arabi, S., et al. (2021) · Journal of Lipids · doi:10.1155/2021/9913969 · Cited by 10
Al-Khateeb, A. M., Hamzan, N. S., Razali, R., Froemming, G. R. A., Rahman, T. H. A., Hoh, B., & Nawawi, H. M. (2016) · International Archives of Medicine · doi:10.3823/2053 · Cited by 8
Metadata
- Authors
- Benn, M., Watts, G. F., Tybjaerg-Hansen, A., & Nordestgaard, B. G.
- Affiliations
- University of Copenhagen (DK)
- The University of Western Australia (AU)
- The Copenhagen General Population Study (M.B., A.T.-H., B.G.N.), Herlev Hospital, Copenhagen University Hospital, DK-2730 Herlev, Denmark
- Corresponding author
- Nordestgaard, Børge G.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2012-11-01
- Volume
- 97
- Issue
- 11
- Pages
- 3956-3964
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W1993634977
- Cited by
- 632
- References
- 38
- Citations by year
- 2026: 28 · 2025: 23 · 2024: 28 · 2023: 37 · 2022: 42 · 2021: 36 · 2020: 44 · 2019: 48 · 2018: 61 · 2017: 80 · 2016: 92 · 2015: 53 · 2014: 42 · 2013: 15 · 2012: 1
- FWCI
- 36.15
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (publishedVersion)
- UWA Profiles and Research Repository (UWA) (submittedVersion)
- Funders
- Amgen
- Pfizer
- AstraZeneca
- Sanofi
- Sundhed og Sygdom, Det Frie Forskningsråd
- Regeneron Pharmaceuticals
- Gentofte Hospital
- Herlev Hospital
- Medical Research Council
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- familial hypercholesterolemia, prevalence, coronary artery disease, cholesterol-lowering drugs, LDLR mutations, APOB mutations, Dutch Lipid Clinic Network criteria, underdiagnosis, undertreatment, myocardial infarction, angina pectoris, Copenhagen General Population Study
- MeSH terms
- Aged, Anticholesteremic Agents, Coronary Artery Disease, Denmark, Female, Genotype, Humans, Hyperlipoproteinemia Type II, Lipids, Lipoproteins, Male, Middle Aged, Risk, Prevalence
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.